Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Receivables - Net: 2014-2024

Historic Receivables - Net for Surgery Partners (SGRY) over the last 10 years, with FY2024 value amounting to $579.1 million.

  • Surgery Partners' Receivables - Net rose 670.47% to $579.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $579.3 million, marking a year-over-year increase of 670.47%. This contributed to the annual value of $579.1 million for FY2024, which is 1666.0% up from last year.
  • Per Surgery Partners' latest filing, its Receivables - Net stood at $579.1 million for FY2024, which was up 1666.0% from $496.4 million recorded in FY2023.
  • In the past 5 years, Surgery Partners' Receivables - Net registered a high of $579.1 million during FY2024, and its lowest value of $382.2 million during FY2020.
  • Its 5-year average for Receivables - Net is $468.8 million, with a median of $456.3 million in 2022.
  • Per our database at Business Quant, Surgery Partners' Receivables - Net surged by 1691.65% in 2020 and then soared by 606.69% in 2022.
  • Over the past 5 years, Surgery Partners' Receivables - Net (Annual) stood at $382.2 million in 2020, then grew by 12.56% to $430.2 million in 2021, then rose by 6.07% to $456.3 million in 2022, then rose by 8.79% to $496.4 million in 2023, then rose by 16.66% to $579.1 million in 2024.
  • Its Receivables - Net stands at $579.1 million for FY2024, versus $496.4 million for FY2023 and $456.3 million for FY2022.